News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Chiron Corporation (CHIR) Submits Written Testimony To Government Reform Committee Hearing On Influenza Vaccine Supply; CEO Howard Pien Pledges Company's Commitment To U.S. Influenza Vaccine Market



10/19/2005 5:11:47 PM

--Chiron Corporation (Nasdaq:CHIR) today announced that president and chief executive officer Howard Pien has submitted written testimony for today's Government Reform Committee Hearing on "The Nation's Flu Shot Shortage: How it Happened and Where We Go From Here."

Read at BioSpace.com


comments powered by Disqus
   
Influenza
Vaccine

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES